107 related articles for article (PubMed ID: 23799775)
1. Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.
Liu J; Zhang D; Li Y; Chen W; Ruan Z; Deng L; Wang L; Tian H; Yiu A; Fan C; Luo H; Liu S; Wang Y; Xiao G; Chen L; Ye W
J Med Chem; 2013 Jul; 56(14):5734-43. PubMed ID: 23799775
[TBL] [Abstract][Full Text] [Related]
2. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK
Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design, SAR analysis and antitumor activity of PI3K/mTOR dual inhibitors from 4-methylpyridopyrimidinone series.
Cheng H; Hoffman JE; Le PT; Pairish M; Kania R; Farrell W; Bagrodia S; Yuan J; Sun S; Zhang E; Xiang C; Dalvie D; Rahavendran SV
Bioorg Med Chem Lett; 2013 May; 23(9):2787-92. PubMed ID: 23506825
[TBL] [Abstract][Full Text] [Related]
4. Bufadienolides from amphibians: A promising source of anticancer prototypes for radical innovation, apoptosis triggering and Na
Sousa LQ; Machado KD; Oliveira SF; Araújo LD; Monção-Filho ED; Melo-Cavalcante AA; Vieira-Júnior GM; Ferreira PM
Toxicon; 2017 Mar; 127():63-76. PubMed ID: 28069354
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a 6-(pyridin-3-yl)benzo[d]thiazole template for optimization of hedgehog and PI3K/AKT/mTOR dual inhibitors.
Yang Z; Ma H; Sun Z; Luo L; Tian S; Zheng J; Zhang X
Bioorg Med Chem Lett; 2015 Sep; 25(17):3665-70. PubMed ID: 26119500
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of human epidermal growth factor receptor 2 by ClC-3 Cl
Fujimoto M; Kito H; Kajikuri J; Ohya S
Cancer Sci; 2018 Sep; 109(9):2781-2791. PubMed ID: 29949674
[TBL] [Abstract][Full Text] [Related]
7. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.
Li H; Jin X; Zhang Z; Xing Y; Kong X
Cell Biochem Funct; 2013 Jul; 31(5):427-33. PubMed ID: 23086777
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of disulfiram/copper complex in the poorly-differentiated nasopharyngeal carcinoma cells via activating ClC-3 chloride channel.
Xu X; Xu J; Zhao C; Hou X; Li M; Wang L; Chen L; Chen Y; Zhu L; Yang H
Biomed Pharmacother; 2019 Dec; 120():109529. PubMed ID: 31606620
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
Zhang HR; Chen JM; Zeng ZY; Que WZ
J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
[TBL] [Abstract][Full Text] [Related]
11. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
[TBL] [Abstract][Full Text] [Related]
12. New inhibitors of the mammalian target of rapamycin signaling pathway for cancer.
Albert S; Serova M; Dreyer C; Sablin MP; Faivre S; Raymond E
Expert Opin Investig Drugs; 2010 Aug; 19(8):919-30. PubMed ID: 20569080
[
